[1] Liver Doctor Editorial Department. The mortality of drug induced liver disease ranked at the fifth in the world. 肝博士,2006,14(5):68-69. [2] 刘玉兰. 王晶桐. 老年人药物性肝损伤的诊治.中华老年医学杂志,2009,28(4):274-275. [3] 刘会领,罗雁. 免疫机制在药物性肝损伤的作用研究进展.实用医学杂志,2012,28(5):852-583. [4] SAN QZM. Antithyroid drugs and drug-induced hepatic injury. Prog Jap Med,2006,27(6):271-273. [5] Onji M,Fujioka S,Takeuchi Y,et al. Clinical characteristics of drug-induced liver injury in elderly. Hepatol Res,2009,39:546-522. [6] 林静,王亚丽,王海燕.老年人急性药物性肝病临床分析30例.世界华人消化杂志,2007,15(18):2059-2062. [7] Taranitino G,Di Minno MN,Capone D.Drug-induced liver injury:is it somehow foreseeable. Word J Gastroenterol,2009,15:2817-2833. [8] 费中明,赵旭宏,郑临. 慢性HBV感染人群与药物肝损伤的研究进展. 浙江医学,2008,30:531-532. [9] Chang CY,Schiano TD. Drug hepatotoxicity. Aliment Pharmacol Ther,2008,25:l135-115l. [10] 饶跃峰,郑飞跃,张幸国.药物性肝损伤的免疫学机制.中国药学杂志,2008,143(116):1207-1210. [11] Kancherla D,Gajendran M,Vallabhaneni P,et al. Metronidazole induced liver injury:A rare immune mediated drug reaction.Gastrointest Med,2013,12(23):1-4. [12] Cho J,Kim L,Li Z,et al.Sex bias in experimental immune-mediated,drug-induced liver injury in BALB/c mice:suggested roles for Tregs,estrogen,and IL-6. Plos One,2013,8(4):83-86. [13] 郭涣珍,冯铁柱,张专才,等. 急性药物性肝损伤的临床特征与治疗措施. 中国医药指南,2013,11(35):465-466. [14] Aithal GP1,Watkins PB,Andrade RJ,et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Phar,2011,89(6):806-815. [15] 吕剑敏,程锐,吴伟东. 导致药物性肝损伤的相关因素分析及针对性干预措施. 世界华人消化杂志,2014,22(3):409-414. |